SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia

BACKGROUND: SARS-CoV-2 antibody testing is required for estimating population seroprevalence and vaccine response studies. It may also increase case identification when used as an adjunct to routine molecular testing. We performed a validation study and evaluated the use of automated high-throughput...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekirov, Inna, Barakauskas, Vilte E., Simons, Janet, Cook, Darrel, Bates, Brandon, Burns, Laura, Masud, Shazia, Charles, Marthe, McLennan, Meghan, Mak, Annie, Chahil, Navdeep, Vijh, Rohit, Hayden, Althea, Goldfarb, David, Levett, Paul N, Krajden, Mel, Morshed, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282439/
https://www.ncbi.nlm.nih.gov/pubmed/34304088
http://dx.doi.org/10.1016/j.jcv.2021.104914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282439/
https://www.ncbi.nlm.nih.gov/pubmed/34304088
http://dx.doi.org/10.1016/j.jcv.2021.104914

Ejemplares similares